Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
127.06
-0.32 (-0.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cardinal Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 136.36, with a low estimate of 120 and a high estimate of 150. The average target predicts an increase of 7.32% from the current stock price of 127.06.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 4 | 5 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 5 | 5 | 5 | 6 | 5 | 5 |
Sell | 1 | 1 | 1 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 12 | 12 | 12 | 13 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Hold → Strong Buy Upgrades $140 → $150 | Hold → Strong Buy | Upgrades | $140 → $150 | +18.05% | Feb 5, 2025 |
JP Morgan | JP Morgan | Hold Maintains $142 → $145 | Hold | Maintains | $142 → $145 | +14.12% | Feb 4, 2025 |
Wells Fargo | Wells Fargo | Hold Maintains $135 → $136 | Hold | Maintains | $135 → $136 | +7.04% | Feb 4, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $136 → $142 | Buy | Maintains | $136 → $142 | +11.76% | Jan 31, 2025 |
Wells Fargo | Wells Fargo | Hold Maintains $127 → $135 | Hold | Maintains | $127 → $135 | +6.25% | Jan 29, 2025 |
Financial Forecast
Revenue This Year
225.26B
from 226.83B
Decreased by -0.69%
Revenue Next Year
244.69B
from 225.26B
Increased by 8.63%
EPS This Year
8.03
from 3.45
Increased by 132.85%
EPS Next Year
9.06
from 8.03
Increased by 12.73%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 236.0B | 264.6B | 285.6B | ||
Avg | 225.3B | 244.7B | 262.5B | ||
Low | 215.5B | 231.6B | 243.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.0% | 17.5% | 16.7% | ||
Avg | -0.7% | 8.6% | 7.3% | ||
Low | -5.0% | 2.8% | -0.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.44 | 9.63 | 10.83 | ||
Avg | 8.03 | 9.06 | 10.00 | ||
Low | 7.75 | 8.57 | 9.46 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 144.7% | 19.9% | 19.5% | ||
Avg | 132.8% | 12.7% | 10.5% | ||
Low | 124.7% | 6.6% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.